Abstract
Streptococcus mutans is a major etiologic agent of human dental caries that forms biofilms on hard tissues in the human oral cavity, such as tooth and dentinal surfaces. Human β-defensin-3 (HBD3) is a 45-amino-acid natural antimicrobial peptide that has broad spectrum antimicrobial activity against bacteria and fungi. A synthetic peptide consisting of the C-terminal 15 amino acids of HBD3 (HBD3-C15) was recently shown to be sufficient for its antimicrobial activity. Thus, clinical applications of this peptide have garnered attention. In this study, we investigated whether HBD3-C15 inhibits the growth of the representative cariogenic pathogen Streptococcus mutans and its biofilm formation. HBD3-C15 inhibited bacterial growth, exhibited bactericidal activity, and attenuated bacterial biofilm formation in a dose-dependent manner. HBD3-C15 potentiated the bactericidal and anti-biofilm activity of calcium hydroxide (CH) and chlorhexidine digluconate (CHX), which are representative disinfectants used in dental clinics, against S. mutans. Moreover, HBD3-C15 showed antimicrobial activity by inhibiting biofilm formation by S. mutans and other dentinophilic bacteria such as Enterococcus faecalis and Streptococcus gordonii, which are associated with dental caries and endodontic infection, on human dentin slices. These effects were observed for HBD3-C15 alone and for HBD3-C15 in combination with CH or CHX. Therefore, we suggest that HBD3-C15 is a potential alternative or additive disinfectant that can be used for the treatment of oral infectious diseases, including dental caries and endodontic infections.
Similar content being viewed by others
References
Arabaci, T., Turkez, H., Canakci, C.F., and Ozgoz, M. 2013. Assessment of cytogenetic and cytotoxic effects of chlorhexidine digluconate on cultured human lymphocytes. Acta Odontol. Scand. 71, 1255–1260.
Bagge, N., Hentzer, M., Andersen, J.B., Ciofu, O., Givskov, M., and Hoiby, N. 2004. Dynamics and spatial distribution of beta-lactamase expression in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 48, 1168–1174.
Batoni, G., Maisetta, G., Brancatisano, F.L., Esin, S., and Campa, M. 2011. Use of antimicrobial peptides against microbial biofilms: Advantages and limits. Curr. Med. Chem. 18, 256–279.
Billings, N., Millan, M., Caldara, M., Rusconi, R., Tarasova, Y., Stocker, R., and Ribbeck, K. 2013. The extracellular matrix component psl provides fast-acting antibiotic defense in Pseudomonas aeruginosa biofilms. PLoS Pathog. 9, e1003526.
Bramante, C.M., Luna-Cruz, S.M., Sipert, C.R., Bernadineli, N., Garcia, R.B., de Moraes, I.G., and de Vasconcelos, B.C. 2008. Alveolar mucosa necrosis induced by utilisation of calcium hydroxide as root canal dressing. Int. Dent. J. 58, 81–85.
Bridier, A., Briandet, R., Thomas, V., and Dubois-Brissonnet, F. 2011. Resistance of bacterial biofilms to disinfectants: A review. Biofouling 27, 1017–1032.
Costerton, J.W., Stewart, P.S., and Greenberg, E.P. 1999. Bacterial biofilms: A common cause of persistent infections. Science 284, 1318–1322.
Dhople, V., Krukemeyer, A., and Ramamoorthy, A. 2006. The human beta-defensin-3, an antibacterial peptide with multiple biological functions. Biochim. Biophys. Acta 1758, 1499–1512.
Diamond, G., Beckloff, N., Weinberg, A., and Kisich, K.O. 2009. The roles of antimicrobial peptides in innate host defense. Curr. Pharm. Des. 15, 2377–2392.
Fujii, G., Selsted, M.E., and Eisenberg, D. 1993. Defensins promote fusion and lysis of negatively charged membranes. Protein Sci. 2, 1301–1312.
Garcia, J.R., Jaumann, F., Schulz, S., Krause, A., Rodriguez-Jimenez, J., Forssmann, U., Adermann, K., Kluver, E., Vogelmeier, C., Becker, D., et al. 2001. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 306, 257–264.
Gillis, R.J., White, K.G., Choi, K.H., Wagner, V.E., Schweizer, H.P., and Iglewski, B.H. 2005. Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 49, 3858–3867.
Gupta, K., Singh, S., and van Hoek, M.L. 2015. Short, synthetic cationic peptides have antibacterial activity against Mycobacterium smegmatis by forming pores in membrane and synergizing with antibiotics. Antibiotics 4, 358–378.
Hamada, S. and Slade, H.D. 1980. Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol. Rev. 44, 331–384.
Hancock, R.E. 1997. Peptide antibiotics. Lancet 349, 418–422.
Harder, J., Bartels, J., Christophers, E., and Schroder, J.M. 2001. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276, 5707–5713.
Hoover, D.M., Rajashankar, K.R., Blumenthal, R., Puri, A., Oppenheim, J.J., Chertov, O., and Lubkowski, J. 2000. The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J. Biol. Chem. 275, 32911–32918.
Hoover, D.M., Wu, Z., Tucker, K., Lu, W., and Lubkowski, J. 2003. Antimicrobial characterization of human beta-defensin 3 derivatives. Antimicrob. Agents Chemother. 47, 2804–2809.
Hou, S., Liu, Z., Young, A.W., Mark, S.L., Kallenbach, N.R., and Ren, D. 2010. Effects of trp-and arg-containing antimicrobial-peptide structure on inhibition of Escherichia coli planktonic growth and biofilm formation. Appl. Environ. Microbiol. 76, 1967–1974.
Jia, H.P., Schutte, B.C., Schudy, A., Linzmeier, R., Guthmiller, J.M., Johnson, G.K., Tack, B.F., Mitros, J.P., Rosenthal, A., Ganz, T., et al. 2001. Discovery of new human beta-defensins using a genomics-based approach. Gene 263, 211–218.
Johnson, B.T. 1995. Uses of chlorhexidine in dentistry. Gen. Dent. 43, 126–132, 134–140.
Jones, C.G. 1997. Chlorhexidine: Is it still the gold standard? Periodontol. 2000 15, 55–62.
Lee, J.K., Chang, S.W., Perinpanayagam, H., Lim, S.M., Park, Y.J., Han, S.H., Baek, S.H., Zhu, Q., Bae, K.S., and Kum, K.Y. 2013a. Antibacterial efficacy of a human beta-defensin-3 peptide on multispecies biofilms. J. Endod. 39, 1625–1629.
Lee, J.K., Park, Y.J., Kum, K.Y., Han, S.H., Chang, S.W., Kaufman, B., Jiang, J., Zhu, Q., Safavi, K., and Spangberg, L. 2013b. Antimicrobial efficacy of a human beta-defensin-3 peptide using an Enterococcus faecalis dentine infection model. Int. Endod. J. 46, 406–412.
Lim, S.M., Ahn, K.B., Kim, C., Kum, J.W., Perinpanayagam, H., Gu, Y., Yoo, Y.J., Chang, S.W., Han, S.H., Shon, W.J., et al. 2016. Antifungal effects of synthetic human beta-defensin 3-C15 peptide. Restor. Dent. Endod. 41, 91–97.
Mah, T.F. and O’Toole, G.A. 2001. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9, 34–39.
Matsumura, K., Furukawa, S., Ogihara, H., and Morinaga, Y. 2011. Roles of multidrug efflux pumps on the biofilm formation of Escherichia coli K-12. Biocontrol Sci. 16, 69–72.
Nguyen, L.T., Haney, E.F., and Vogel, H.J. 2011. The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 29, 464–472.
Petrov, V., Funderburg, N., Weinberg, A., and Sieg, S. 2013. Human beta defensin-3 induces chemokines from monocytes and macrophages: Diminished activity in cells from hiv-infected persons. Immunology 140, 413–420.
Rafter, M. 2005. Apexification: A review. Dent. Traumatol. 21, 1–8.
Sass, V., Schneider, T., Wilmes, M., Korner, C., Tossi, A., Novikova, N., Shamova, O., and Sahl, H.G. 2010. Human beta-defensin 3 inhibits cell wall biosynthesis in staphylococci. Infect. Immun. 78, 2793–2800.
Schibli, D.J., Hunter, H.N., Aseyev, V., Starner, T.D., Wiencek, J.M., McCray, P.B. Jr., Tack, B.F., and Vogel, H.J. 2002. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J. Biol. Chem. 277, 8279–8289.
Siqueira, J.F. Jr. and Lopes, H.P. 1999. Mechanisms of antimicrobial activity of calcium hydroxide: A critical review. Int. Endod. J. 32, 361–369.
Vu, M., Rajgopal Bala, H., Cahill, J., Toholka, R., and Nixon, R. 2017. Immediate hypersensitivity to chlorhexidine. Australas. J. Dermatol. DOI: 10.1111/ajd.12674.
Wimley, W.C., Selsted, M.E., and White, S.H. 1994. Interactions between human defensins and lipid bilayers: Evidence for formation of multimeric pores. Protein Sci. 3, 1362–1373.
Yamasaki, K. and Gallo, R.L. 2008. Antimicrobial peptides in human skin disease. Eur. J. Dermatol. 18, 11–21.
Yang, D., Chertov, O., Bykovskaia, S.N., Chen, Q., Buffo, M.J., Shogan, J., Anderson, M., Schroder, J.M., Wang, J.M., Howard, O.M., et al. 1999. Beta-defensins: Linking innate and adaptive immunity through dendritic and t cell CCR6. Science 286, 525–528.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahn, K.B., Kim, A.R., Kum, KY. et al. The synthetic human beta-defensin-3 C15 peptide exhibits antimicrobial activity against Streptococcus mutans, both alone and in combination with dental disinfectants. J Microbiol. 55, 830–836 (2017). https://doi.org/10.1007/s12275-017-7362-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-017-7362-y